vs
Lakeside Holding Ltd（LSH）与NATURAL HEALTH TRENDS CORP（NHTC）财务数据对比。点击上方公司名可切换其他公司
NATURAL HEALTH TRENDS CORP的季度营收约是Lakeside Holding Ltd的1.4倍（$9.7M vs $7.0M），NATURAL HEALTH TRENDS CORP净利率更高（-6.0% vs -22.6%，领先16.6%），Lakeside Holding Ltd同比增速更快（95.0% vs -10.1%）
莱克赛德出版社是位于美国芝加哥的出版品牌，由RR唐纳利公司运营。该社除了出版高品质书籍外，还承印邮购目录、电话号码簿、百科全书与广告宣传品，最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本，以及经典重印丛书《莱克赛德经典》。
Sword Health是一家数字医疗企业，专注开发针对肌肉骨骼疾病、骨盆健康与损伤预防的物理治疗方案。该企业2015年由Virgílio Bento与Márcio Colunas在葡萄牙创立，将人工智能融入护理模式，提供数字化物理治疗服务。截至2024年，Sword Health已开展国际化运营，在美国、爱尔兰与葡萄牙均设有办公室。
LSH vs NHTC — 直观对比
营收规模更大
NHTC
是对方的1.4倍
$7.0M
营收增速更快
LSH
高出105.1%
-10.1%
净利率更高
NHTC
高出16.6%
-22.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.0M | $9.7M |
| 净利润 | $-1.6M | $-588.0K |
| 毛利率 | 27.2% | 72.9% |
| 营业利润率 | -21.3% | -6.5% |
| 净利率 | -22.6% | -6.0% |
| 营收同比 | 95.0% | -10.1% |
| 净利润同比 | 18.7% | -434.1% |
| 每股收益（稀释后） | $-0.08 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSHNHTC
| Q4 25 | $7.0M | $9.7M | ||
| Q3 25 | $6.1M | $9.5M | ||
| Q2 25 | $6.3M | $9.8M | ||
| Q1 25 | $3.8M | $10.7M | ||
| Q4 24 | $3.6M | $10.8M | ||
| Q3 24 | $4.1M | $10.7M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | — | $11.0M |
净利润LSHNHTC
| Q4 25 | $-1.6M | $-588.0K | ||
| Q3 25 | $-1.4M | $-431.0K | ||
| Q2 25 | $-893.1K | $15.0K | ||
| Q1 25 | $-1.1M | $122.0K | ||
| Q4 24 | $-1.9M | $176.0K | ||
| Q3 24 | $-1.3M | $35.0K | ||
| Q2 24 | — | $173.0K | ||
| Q1 24 | — | $188.0K |
毛利率LSHNHTC
| Q4 25 | 27.2% | 72.9% | ||
| Q3 25 | 18.2% | 73.7% | ||
| Q2 25 | 26.7% | 73.9% | ||
| Q1 25 | 18.8% | 73.6% | ||
| Q4 24 | -1.2% | 74.2% | ||
| Q3 24 | 12.8% | 74.1% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 73.4% |
营业利润率LSHNHTC
| Q4 25 | -21.3% | -6.5% | ||
| Q3 25 | -20.8% | -5.2% | ||
| Q2 25 | -8.9% | -3.4% | ||
| Q1 25 | -28.2% | -3.2% | ||
| Q4 24 | -55.6% | -3.9% | ||
| Q3 24 | -32.5% | -2.6% | ||
| Q2 24 | — | -2.3% | ||
| Q1 24 | — | -3.3% |
净利率LSHNHTC
| Q4 25 | -22.6% | -6.0% | ||
| Q3 25 | -22.2% | -4.5% | ||
| Q2 25 | -14.2% | 0.2% | ||
| Q1 25 | -28.2% | 1.1% | ||
| Q4 24 | -54.1% | 1.6% | ||
| Q3 24 | -32.7% | 0.3% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | 1.7% |
每股收益（稀释后）LSHNHTC
| Q4 25 | $-0.08 | $-0.05 | ||
| Q3 25 | $-0.09 | $-0.04 | ||
| Q2 25 | $-0.11 | $0.00 | ||
| Q1 25 | $-0.14 | $0.01 | ||
| Q4 24 | $-0.26 | $0.01 | ||
| Q3 24 | $-0.18 | $0.00 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | — | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6M | $28.9M |
| 总债务越低越好 | $2.4M | — |
| 股东权益账面价值 | $12.2M | $23.4M |
| 总资产 | $24.3M | $38.4M |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势，按日历期对齐
现金及短期投资LSHNHTC
| Q4 25 | $1.6M | $28.9M | ||
| Q3 25 | $4.5M | $32.0M | ||
| Q2 25 | $5.0M | $34.2M | ||
| Q1 25 | $1.5M | $41.9M | ||
| Q4 24 | $1.1M | $43.9M | ||
| Q3 24 | $2.7M | $46.3M | ||
| Q2 24 | — | $48.7M | ||
| Q1 24 | — | $54.4M |
总债务LSHNHTC
| Q4 25 | $2.4M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $774.2K | — | ||
| Q4 24 | $784.8K | — | ||
| Q3 24 | $589.9K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LSHNHTC
| Q4 25 | $12.2M | $23.4M | ||
| Q3 25 | $7.0M | $26.1M | ||
| Q2 25 | $2.8M | $28.9M | ||
| Q1 25 | $749.8K | $30.9M | ||
| Q4 24 | $1.6M | $32.9M | ||
| Q3 24 | $3.6M | $35.3M | ||
| Q2 24 | — | $37.3M | ||
| Q1 24 | — | $39.4M |
总资产LSHNHTC
| Q4 25 | $24.3M | $38.4M | ||
| Q3 25 | $18.6M | $42.3M | ||
| Q2 25 | $14.4M | $45.2M | ||
| Q1 25 | $9.9M | $53.2M | ||
| Q4 24 | $9.8M | $55.4M | ||
| Q3 24 | $10.8M | $58.3M | ||
| Q2 24 | — | $61.5M | ||
| Q1 24 | — | $67.6M |
负债/权益比LSHNHTC
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-453.5K | $-959.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-964.0K |
| 自由现金流率自由现金流/营收 | — | -9.9% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-6.1M |
8季度趋势，按日历期对齐
经营现金流LSHNHTC
| Q4 25 | $-453.5K | $-959.0K | ||
| Q3 25 | $-4.0M | $113.0K | ||
| Q2 25 | $-483.7K | $-5.6M | ||
| Q1 25 | $-238.3K | $484.0K | ||
| Q4 24 | $-530.2K | $88.0K | ||
| Q3 24 | $-1.4M | $-436.0K | ||
| Q2 24 | — | $-3.6M | ||
| Q1 24 | — | $549.0K |
自由现金流LSHNHTC
| Q4 25 | — | $-964.0K | ||
| Q3 25 | — | $70.0K | ||
| Q2 25 | $-497.4K | $-5.6M | ||
| Q1 25 | — | $468.0K | ||
| Q4 24 | $-560.5K | $68.0K | ||
| Q3 24 | $-1.4M | $-443.0K | ||
| Q2 24 | — | $-3.6M | ||
| Q1 24 | — | $538.0K |
自由现金流率LSHNHTC
| Q4 25 | — | -9.9% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | -7.9% | -57.5% | ||
| Q1 25 | — | 4.4% | ||
| Q4 24 | -15.6% | 0.6% | ||
| Q3 24 | -34.5% | -4.1% | ||
| Q2 24 | — | -34.2% | ||
| Q1 24 | — | 4.9% |
资本支出强度LSHNHTC
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.8% | 0.2% | ||
| Q3 24 | 0.1% | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.1% |
现金转化率LSHNHTC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -375.67× | ||
| Q1 25 | — | 3.97× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | -12.46× | ||
| Q2 24 | — | -20.62× | ||
| Q1 24 | — | 2.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |
NHTC
暂无分部数据
